Pharmacokinetics and safety of the novel amino-3-hydroxy-5- methylisoxazole-4-propionate receptor antagonist YM90K in healthy men

Journal of Clinical Pharmacology

Volumn 37, Issue 8, 1997, Pages 719-727

  Umemura, Kazuo ^a   Kondo, Kazunao ^a   Ikeda, Yasuhiko ^a   Teraya, Yukari ^a   Yoshida, Hisatomo ^a   Homma, Mariko ^a   Uematsu, Toshihiko ^a,b   Nakashima, Mitsuyoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR ANTAGONIST;

ARTICLE; BRAIN PROTECTION; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG SAFETY; DRUG TOLERANCE; HUMAN; MALE; NERVE DEGENERATION; NORMAL HUMAN; STROKE;

EID: 0030770855     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb04359.x     Document Type: Article

References (16)

1. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986;19:105-111.
2. Choi DW: Glutamate neurotoxicity and diseases in the nervous system. Neuron 1988;1:623-634.
3. Lekieffe D, Meldrum BS: The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats: a microdialysis and histological study. Neuroscience 1993;56:93-99.
4. Tsuyuki YU, Araki H, Yae T, Otomo S: Changes in the extracellular concentrations of amino acids in the rat striatum during transient focal cerebral ischemia. J Neurochem 1994;62:1074-1078.
5. Baldwin HA, Williams JL, Snares M, Ferreira T, Cross AJ, Green AR: Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. Br J Pharmacol 1994;112:188-194.
6. Wahl F, Obrenovitch TP, Hardy AM, Plotkine M, Boulu R, Symon L: Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium dependency. J Neurochem 1994;63:1003-1011.
7. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J: The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 1988;24:543-551.
8. Gill R, Brazell C, Woodruff GN, Kemp JA: The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia. Br J Pharmacol 1991; 103:2030-2036.
9. Koek W, Wood JH, Winger GD: MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 1988;245:969-974.
10. Morris RGM, Anderson E, Lynch GS, Baudry M: Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986; 319:774-776.
11. Olney JW, Labruyere J, Price MT: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989;244:1360-1362.
12. Ohmori J, Sakamoto S, Kubota H, Shimizu-Sasamata M, Okada M, Kawasaki S, et al: 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor. J Med Chem 1994;37:467-475.
13. Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, et al: YM90K: pharmacological characterization as a selective and potent α -amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist. J Pharmacol Exp Ther 1996;276:84-92.
14. Li H, Buchan AM: Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J Cereb Blood Flow Metab 1993;13:933-939.
15. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T: 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 1990;247:571-574.
16. Bertrand G, Gross R, Puech R, Loubatieres-Mariani MM, Bockaert J: Evidence for a glutamate receptor of the AMPA subtype which mediates insulin release from rat perfused pancreas. Br J Pharmacol 1992;106:354-359.